Peripheral Arterial Diseases
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
LP
Lee's PharmaceuticalChina - Guangzhou
1 program1
Propionyl-L-Carnitine HydrochloridePhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cordisballoon angioplasty
Lee's PharmaceuticalPropionyl-L-Carnitine Hydrochloride
Clinical Trials (2)
Total enrollment: 212 patients across 2 trials
Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease
Start: Mar 2008Est. completion: Jan 2011200 patients
Phase 4Completed
PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses
Start: Jun 2015Est. completion: Jan 201612 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space